Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Aurora Cannabis

Canopy Growth

Tilray Brands

On Oct. 17, 2018, Canada made history by becoming the first G7 country and the second country overall to legalize adult-use cannabis.

Study Says Canadian Cannabis Market Could Reach $5.2B By 2024: 4 Provinces To Watch

Aphria

These brand-name pot stocks have some pretty glaring deficiencies.

Here's Why the 5 Most Popular Marijuana Stocks Aren't Worth Buying

HEXO Corp

With talk of a looming recession, analysts predict that given a downturn there will be a short list of growth industries capable of delivering a healthy return on investment.

5 Key Factors To Consider Before Making A Cannabis Acquisition

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

GW Pharmaceuticals

Innovative Industrial Properties

Village Farms International

Mirror, mirror, on the wall, these were the greenest marijuana stocks of all.

These 14 Pot Stocks Gained at Least 70% in the First Quarter

CannTrust Holdings

Amplify Alternative Harvest ETF

Scotts Miracle-Gro

The week brought big cannabis news, with the FDA setting its first hearing regarding CBD's legality in food and drinks for May, and the STATES Act, which aims to protect cannabis businesses and users in legal states from federal intervention, being introduced in Congress.

This Week's Cannabis News: The FDA And CBD, The STATES Act, Cresco And Origin House, Europe And High Times

CVS Health

Walgreens

Global CBD sales could soar by 147% annually over the next four years.

9 Things You Must Know About CBD Before Investing in Pot Stocks

Consolidation and equity investments are picking up steam as the green rush takes shape.

The 5 Largest Marijuana Deals in History

Hint: It's not the biggest of the big players.

Which Big Canadian Marijuana Stock Has the Most Upside Potential Right Now?

Sales are soaring, but so are operating losses for most pot stocks.

Marijuana Stock Earnings: A Comprehensive Look at First-Quarter Results

New Age Beverages

The cannabis space cooled down last month, due in part to a spate of quarterly earnings releases that failed to excite investors.

Why Marijuana Stocks Tilray, Cronos, and New Age Beverages Fell 10% to 19% in March

Cronos is the new third-largest pot stock, but it has no business being listed side by side with its larger peers.

Cronos Group Can't Hold a Candle to Aurora Cannabis or Canopy Growth

A ranking of the top marijuana growers by sales in the most recent quarter.

Here's Who Sold the Most Marijuana Last Quarter

These marijuana companies are issuing stock like it's going out of style, and it's shareholders who could pay the price.

Pot Stock Share-Based Dilution: 5 of the Worst Offenders

An industry worth $910 million in 2015 reached $13.8 billion in 2018, and it seems bound only sunward yet: The bottom line is, the sky’s the limit.

For Cannabis Industry Investment, 2018 Was Terrific But 2019 Looks Even Better

Three downgrades following a subpar fourth-quarter earnings report suggest the tide is shifting for this popular pot stock.

Wall Street Is Finally Wising Up on Cronos Group

Two leaders, two laggards, and one in the group of top marijuana stocks that's most likely to succeed in the States.

Which Canadian Marijuana Stock Is Best Poised to Win in the U.S.: Aurora Cannabis, Cronos, Canopy Growth, or Tilray?

The results are in -- and it's clear who the winners are so far in Canada's recreational marijuana market.

Canadian Recreational Pot Market: How the Big 5 Marijuana Growers Compare

Shares are slipping after disappointing results, but its deep pockets could make it a cannabis company worth owning.

Is Marijuana Stock Cronos Group a Buy?

It’s that time again. The Benzinga Events team is busy planning for the third Cannabis Capital Conference back in one of our favorite spots and the heart of the cannabis industry—Toronto.

Preparing For Toronto: Cannabis LP Executives To Talk About The Canadian Market

Cronos's fourth-quarter results show that it doesn't belong in the same tier as the major cannabis players.

Cronos Group Is the Most Overvalued Pot Stock and Its Quarterly Report Proves It

The vote for the SAFE Banking Act adds to the marijuana industry's momentum in Washington since November. 
The post Marijuana Stocks Edge Closer To Removing Huge U.S. Obstacle appeared first on Investor's Business Daily.

Marijuana Stocks Edge Closer To Removing Huge U.S. Obstacle

Wall Street has turned sour on Cronos' near-term outlook. Should everyday investors do the same?

Cronos Group: Buy the Dip?

Investors are taking a closer look at yesterday's not-so-great earnings report.

Here's Why Cronos Group Is Sliding Today

Cronos Group, a vertically integrated Canadian marijuana producer, published its Q4 and full year 2018 results on Tuesday, missing market and Trefis expectations.

Key Takeaways From Cronos Group's Q4 Earnings

Cannabis stocks had a huge showing on Wall Street this past fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

News for Cronos Group Stock (CRON)